T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.18% |
| 2 | Consumer Discretionary | 14.97% |
| 3 | Financials | 14.24% |
| 4 | Technology | 12.89% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEMP
1501
DELISTED
Cempra, Inc.
CEMP
| $2.12M | ﹤0.01% |
128,686
| – | – |
|
1502
Dr. Reddy's Laboratories
RDY
$10.2B
| $2.11M | ﹤0.01% |
206,195
+69,815
| +51% | +$640K |
|
|
TWOU
1503
DELISTED
2U Inc
TWOU
| $2.1M | ﹤0.01% |
2,386
-1,266
| -35% | -$1.03M |
|
|
LPT
1504
DELISTED
Liberty Property Trust
LPT
| $2.09M | ﹤0.01% |
52,568
-5,285
| -9% | -$192K |
|
|
PNY
1505
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $2.08M | ﹤0.01% |
34,677
-2,633
| -7% | -$158K |
|
1506
Lamar Advertising Co
LAMR
$15.8B
| $2.08M | ﹤0.01% |
31,418
-1,590
| -5% | -$100K |
|
1507
AGNC Investment
AGNC
$13.1B
| $2.08M | ﹤0.01% |
104,799
-7,207
| -6% | -$136K |
|
1508
Starwood Property Trust
STWD
$6.08B
| $2.07M | ﹤0.01% |
99,732
+19,944
| +25% | +$398K |
|
|
CSOD
1509
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $2.06M | ﹤0.01% |
54,114
+500
| +0.9% | +$18.6K |
|
1510
CoreCivic
CXW
$3.26B
| $2.06M | ﹤0.01% |
58,770
+2,422
| +4% | +$79.5K |
|
1511
American Financial Group
AFG
$12.1B
| $2.06M | ﹤0.01% |
27,801
-300
| -1% | -$21.3K |
|
1512
John Wiley & Sons Class A
WLY
$2.61B
| $2.05M | ﹤0.01% |
39,368
-8,700
| -18% | -$439K |
|
|
SRC
1513
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $2.05M | ﹤0.01% |
35,811
-4,754
| -12% | -$248K |
|
1514
Voya Financial
VOYA
$9.2B
| $2.03M | ﹤0.01% |
82,042
+9,159
| +13% | +$280K |
|
1515
Oshkosh
OSK
$9.55B
| $2.03M | ﹤0.01% |
42,516
+5,491
| +15% | +$244K |
|
1516
Arch Capital
ACGL
$33.6B
| $2.03M | ﹤0.01% |
84,459
+6,867
| +9% | +$162K |
|
|
EGN
1517
DELISTED
Energen
EGN
| $2.02M | ﹤0.01% |
41,841
+870
| +2% | +$37.9K |
|
|
QEP
1518
DELISTED
QEP RESOURCES, INC.
QEP
| $2.01M | ﹤0.01% |
114,190
+3,300
| +3% | +$57K |
|
|
ITC
1519
DELISTED
ITC HOLDINGS CORP
ITC
| $1.96M | ﹤0.01% |
41,940
+23
| +0.1% | +$1.02K |
|
|
LSI
1520
DELISTED
Life Storage, Inc.
LSI
| $1.96M | ﹤0.01% |
28,028
+10,043
| +56% | +$729K |
|
1521
Brown-Forman Class A
BF.A
$13.1B
| $1.95M | ﹤0.01% |
45,000
| – | – |
|
1522
SM Energy
SM
$7.94B
| $1.94M | ﹤0.01% |
71,844
+9,272
| +15% | +$260K |
|
1523
Bio-Techne
TECH
$11.2B
| $1.94M | ﹤0.01% |
68,828
-3,896
| -5% | -$100K |
|
1524
Commercial Metals
CMC
$8.01B
| $1.93M | ﹤0.01% |
114,400
| – | – |
|
1525
Enpro
NPO
$7.2B
| $1.92M | ﹤0.01% |
43,278
+3,100
| +8% | +$160K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.